Results

Total Results: 71 records

Showing results for "buprenorphine".

1. Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
   August 01, 2020 - Buprenorphine extended-release 6-month implant Daily SL- buprenorphine 1 RCT29 n=177 1 good … treatment were randomized to receive in-person buprenorphine MAT (TAU) or buprenorphine MAT plus a … /naloxone, and buprenorphine). … pharmacotherap* or pharmaco-therap* or substitution or therap* or treat*))).ti,ab,kf. 52155 6 (Belbuca or Buprenex … pharmacotherap* or pharmaco-therap* or substitution or therap* or treat*))).ti,ab,kf. 104 3 (Belbuca or Buprenex

2. #14 SUBSTANCE ABUSE (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
   January 01, 2012 - *Buprenorphine implant for treatment of opioid dependence 2. … tablet induction followed by a buprenorphine implant placed under the skin in a physician’s office … Two novel, long-acting versions of currently used pharmacotherapies (buprenorphine and naltrexone) … For those experts who compared the buprenorphine implant delivery system to other buprenorphine formulations … About buprenorphine therapy. [internet].

3. Topic-Brief3-Sud (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief3-SUD.pdf
   April 01, 2021 - A randomized trial of reduced versus full-dose buprenorphine/naloxone is currently in progress (expected … In such patients, traditional approaches include discontinuation of buprenorphine or naltrexone and … treated for pain with opioid analgesics while continuing buprenorphine … Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. … Patients maintained on buprenorphine for opioid use disorder should continue buprenorphine through

4. Topic-Brief3-Sud (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief3-SUD.pdf
   April 01, 2021 - A randomized trial of reduced versus full-dose buprenorphine/naloxone is currently in progress (expected … In such patients, traditional approaches include discontinuation of buprenorphine or naltrexone and … treated for pain with opioid analgesics while continuing buprenorphine … Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. … Patients maintained on buprenorphine for opioid use disorder should continue buprenorphine through

5. Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/retention-strategies-opioid-use-disorder/rapid-research
   August 21, 2020 - Early studies suggest no difference in retention with XR-buprenorphine in either injectable or implant … formulations compared with daily buprenorphine. … There were conflicting results with XR-naltrexone injection compared with daily buprenorphine. … XR and daily buprenorphine formulations appear to be equivalent for treatment retention and comparisons … of XR-naltrexone versus daily buprenorphine showed conflicting results.

6. #14 SUBSTANCE ABUSE (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
   January 01, 2012 - For this condition, pharmacotherapy (e.g., buprenorphine, naltrexone) is already available in oral, … Implanted buprenorphine (Probuphine ™ , Titan Pharmaceuticals, Inc., South San Francisco, CA) is … Buprenorphine is a partial opioid agonist that is known to reduce opioid cravings and is U.S. … For the experts who compared the buprenorphine implant delivery system to other buprenorphine formulations … About buprenorphine therapy. [internet].

7. #14 SUBSTANCE ABUSE (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
   January 01, 2012 - *Buprenorphine implant (Probuphine) for treatment of opioid dependence Moderately high 3. … For this condition, pharmacotherapy (e.g., buprenorphine, naltrexone) is already available in oral, … ES-4 o Implanted buprenorphine (Probuphine™, Titan Pharmaceuticals, Inc., South San Francisco, CA) … For the experts who compared the buprenorphine implant delivery system to other buprenorphine formulations … About buprenorphine therapy. [internet].

8. Disposition of Comments for Technical Brief 28 MAT Models (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-use-disorder_disposition-comments.pdf
   December 06, 2016 - HCl/naloxone HCl dihydrate, sublingual tablet) and SUBUTEX® (buprenorphine HCl, sublingual tablet) … As the Food & Drug Administration (“FDA”) noted specifically concerning suboxone and subutex, “pharmacists … before we even entertained sublinqual buprenorphine. … buprenorphine. … buprenorphine.

9. #14 SUBSTANCE ABUSE (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
   June 01, 2013 - Buprenorphine implant (Probuphine) for treatment of opioid dependence No high-impact potential at this … The topic, buprenorphine implant (Probuphine,™ Titan Pharmaceuticals, Inc., South San Francisco, CA … system that includes a sublingual buprenorphine-naloxone tablet induction followed by a buprenorphine … For this condition, pharmacotherapy (e.g., buprenorphine, naltrexone) is already available in oral, … Available short-acting treatments for opioid dependence (e.g., naltrexone, methadone, buprenorphine

10. CER 225: Evidence Summary Interventions for Substance Use Disorders in Adolescents: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-225-substance-abuse-adolescents-evidence-summary%20225%20Substance%20Use%20Adolescents.pdf
    May 01, 2020 - disorders Pharmacological interventions  In opioid use disorder, longer courses (2–3 months) of buprenorphine … /buprenorphine-naloxone are more effective than shorter courses (14–28 days) to reduce days of opioid … to a more than 4 times greater likelihood of abstinence with an extended (2 to 3 month) course of buprenorphine … Similarly, a slow buprenorphine taper (over 56 days) was more effective than a 28-day taper. … For opioid use disorder, buprenorphine and buprenorphine-naloxone are more effective for the short-term

11. Interventions for Substance Use Disorders in Adolescents: A Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/substance-use-disorders-adolescents/research
    May 21, 2020 - disorders: Pharmacological interventions: In opioid use disorder, longer courses (2–3 months) of buprenorphine … /buprenorphine-naloxone are more effective than shorter courses (14–28 days) to reduce days of opioid … led to a more than 4 times greater likelihood of abstinence with extended courses (2 to 3 months) of buprenorphine … Pharmacological interventions: longer courses of buprenorphine (2–3 months) are more effective than

12. Topic-Brief2-Opioid-Withdrawal (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief2-opioid-withdrawal.pdf
    April 01, 2021 - Buprenorphine is a partial opioid agonist that can treat pain effectively in certain patients, as well … It should be noted that use of buprenorphine formulations approved for treatment of opioid use 9 … However, publication of in-progress randomized trials on behavioral support and buprenorphine-assisted … Understanding buprenorphine for use in chronic pain: expert opinion. … Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper.

13. Topic-Brief2-Opioid-Withdrawal (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
    April 01, 2021 - Buprenorphine is a partial opioid agonist that can treat pain effectively in certain patients, as well … It should be noted that use of buprenorphine formulations approved for treatment of opioid use 9 … However, publication of in-progress randomized trials on behavioral support and buprenorphine-assisted … Understanding buprenorphine for use in chronic pain: expert opinion. … Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper.

14. Opioid Treatments for Chronic Pain | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/opioids-chronic-pain/research
    April 16, 2020 - Trials of patients with prescription opioid dependence found buprenorphine maintenance associated with … better outcomes than buprenorphine taper and similar effects of methadone versus buprenorphine.

15. Appendixes (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendixes-surveillance-report-1.pdf
    September 30, 2021 - (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone or morphine or oxycodone … (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone or morphine or oxycodone … Mobile, Community-Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid … Buprenorphine Buccal Film Improves Patient Global Impression of Change and Reduces the Prevalence … Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain.

16. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
    April 01, 2022 - • One small new RCT of buprenorphine/naloxone versus methadone for treatment of opioid use disorder … Treatment of opioid use disorder (buprenorphine/naloxone vs. methadone) No difference between buprenorphine … Mobile, Community-Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid … Buprenorphine Buccal Film Improves Patient Global Impression of Change and Reduces the Prevalence … Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain.

17. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-2.pdf
    April 01, 2022 - Treatment of opioid use disorder (buprenorphine/naloxone vs. methadone) No difference between buprenorphine … Randomized clinical trial comparing buprenorphine/naloxone and methadone for the treatment of patients … Buprenorphine Buccal Film Improves Patient Global Impression of Change and Reduces the Prevalence … Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain. … Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone

18. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/opioid-chronic-pain-surveillance-report-2.pdf
    April 01, 2022 - Treatment of opioid use disorder (buprenorphine/naloxone vs. methadone) No difference between buprenorphine … Randomized clinical trial comparing buprenorphine/naloxone and methadone for the treatment of patients … Buprenorphine Buccal Film Improves Patient Global Impression of Change and Reduces the Prevalence … Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain. … Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone

19. #14 SUBSTANCE ABUSE (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - Buprenorphine implant (Probuphine) for treatment of opioid dependence No high-impact potential at this … The topic, buprenorphine implant (Probuphine™, Titan Pharmaceuticals, Inc., South San Francisco, CA … followed by a buprenorphine implant placed under the skin in a physician’s office and removed after … Available short-acting treatments for opioid dependence (e.g., naltrexone, methadone, buprenorphine … The 6-month buprenorphine implant completed phase III trials, one of which was funded by the National

20. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
    June 01, 2022 - Treatment of opioid use disorder (buprenorphine/naloxone vs. methadone) No difference between buprenorphine … Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic … Changes in pain during buprenorphine maintenance treatment among patients with opioid use disorder … Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain. … Optimizing opioid use disorder treatment with naltrexone or buprenorphine.